--- title: "111, Inc. Sponsored ADR (NASDAQ:YI) Short Interest Down 33.5% in February" type: "News" locale: "en" url: "https://longbridge.com/en/news/277356308.md" description: "111, Inc. Sponsored ADR (NASDAQ:YI) experienced a 33.5% decrease in short interest in February, with total short interest falling to 25,958 shares from 39,019 shares. Approximately 0.5% of the company's stock is sold short, resulting in a days-to-cover ratio of 0.4 days based on an average trading volume of 61,821 shares. The stock opened at $7.91, down 2.1%, with a market cap of $68.34 million and a PE ratio of -9.42. Analysts currently rate the stock as a \"Sell.\"" datetime: "2026-03-01T13:00:04.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/277356308.md) - [en](https://longbridge.com/en/news/277356308.md) - [zh-HK](https://longbridge.com/zh-HK/news/277356308.md) --- # 111, Inc. Sponsored ADR (NASDAQ:YI) Short Interest Down 33.5% in February 111, Inc. Sponsored ADR (NASDAQ:YI - Get Free Report) saw a significant decrease in short interest during the month of February. As of February 13th, there was short interest totaling 25,958 shares, a decrease of 33.5% from the January 29th total of 39,019 shares. Approximately 0.5% of the shares of the stock are sold short. Based on an average daily volume of 61,821 shares, the short-interest ratio is currently 0.4 days. Based on an average daily volume of 61,821 shares, the short-interest ratio is currently 0.4 days. Approximately 0.5% of the shares of the stock are sold short. ## 111 Stock Down 2.1% Shares of YI opened at $7.91 on Friday. The stock's fifty day simple moving average is $5.62 and its 200-day simple moving average is $5.10. The firm has a market capitalization of $68.34 million, a PE ratio of -9.42 and a beta of 0.67. 111 has a 12-month low of $2.48 and a 12-month high of $11.35. 111 (NASDAQ:YI - Get Free Report) last issued its quarterly earnings results on Wednesday, December 17th. The company reported ($1.20) EPS for the quarter. The firm had revenue of $421.49 million for the quarter. ## Analyst Ratings Changes Separately, Weiss Ratings reissued a "sell (e+)" rating on shares of 111 in a report on Monday, December 29th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has an average rating of "Sell". **Check Out Our Latest Analysis on YI** ## 111 Company Profile (Get Free Report) 111, Inc NASDAQ: YI is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide. 111, Inc's product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods. ## Featured Stories - Five stocks we like better than 111 - The gold chart Wall Street is terrified of… - This makes me furious - America’s 1776 happening again - Buy this Gold Stock Before May 2026 - “Fed Proof” Your Bank Account with THESE 4 Simple Steps _This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com._ ## Should You Invest $1,000 in 111 Right Now? Before you consider 111, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and 111 wasn't on the list. While 111 currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [YI.US](https://longbridge.com/en/quote/YI.US.md) ## Related News & Research - [111, Inc. Posts Lower Q1 2026 Revenue as Asset-Light Shift Boosts High-Margin Services](https://longbridge.com/en/news/288711030.md) - [Scott Bessent assures Americans Fort Knox gold is still there — then reminds them the dollar is no longer backed by it. Is your money safe?](https://longbridge.com/en/news/294607647.md) - [YXT.com regains Nasdaq $1 minimum bid price compliance](https://longbridge.com/en/news/294506083.md) - [GD Culture Group regains Nasdaq compliance on $1 minimum bid price rule](https://longbridge.com/en/news/294551670.md) - [AmBase receives additional $1 million litigation funding for 111 West 57th property dispute](https://longbridge.com/en/news/294542887.md)